Background illustration for clinical trials search

Paid Clinical Trials Akron

Discover 1,444 paid clinical trials in Akron, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease

for
HR+/HER2- Breast Cancer
Location: Canton OH, Detroit MI, Dayton OH, Fort Wayne IN,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07492641

Phase 3, Recruiting

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Canton OH, Detroit MI, Dayton OH, Cincinnati OH,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07518186

Phase 3, Recruiting

INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)

for
Polycythemia Vera
Location: Canton OH, Columbus OH, Grand Rapids MI, Bethesda MD,
Sponsor: Ono Pharmaceutical Co., Ltd.

Sex: All

Age: 18+

Code: NCT07429266

Phase 3, Recruiting

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

for
Ras-mutated Metastatic Colorectal Cancer, mCRC,
Location: Canton OH, Colombus OH, Detroit MI, Cincinnati OH,
Sponsor: Oncolytics Biotech

Sex: All

Age: 18+

Code: NCT07446322

Phase 2, Recruiting

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

for
Breast Neoplasms, Neoplasm Metastasis
Location: Canton OH, Columbus OH, Edgewood KY, Frederick MD,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07174336

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)

for
Metastatic Castration Resistant Prostate Cancer
Location: Canton OH, Holland MI, Lancaster PA, Jeffersonville IN,
Sponsor: ORIC Pharmaceuticals

Sex: Male

Age: 18+

Code: NCT07723248

Phase 3, Recruiting

Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer
Location: Canton OH, Hinsdale IL, Westbury NY, Wilson NC,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06899126

Phase 3, Recruiting

A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United States

for
Advanced Unresectable Gastric Adenocarcinoma,
Location: Canton OH, St Louis MO, Coral Springs FL, Tamarac FL,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07554521

Phase 2, Recruiting

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

for
Leukemia, Myeloid, Acute
Location: Canton OH, Cleveland OH, Pittsburgh PA, Detroit MI,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06852222

Phase 3, Recruiting

Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment

for
Advanced Solid Tumors, Hematologic Malignancies
Location: Canton OH, Detroit MI, Chicago IL
Sponsor: Acrotech Biopharma Inc.

Sex: All

Age: 18+

Code: NCT07036133

Phase 1, Recruiting

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

for
Lymphoid Malignancies
Location: Canton OH, Louisville KY, Chicago IL, Memphis TN,
Sponsor: AVM Biotechnology Inc

Sex: All

Age: 12 - 70+

Code: NCT04329728

Phase 1, Phase 2, Recruiting

A Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)

for
Carcinoma, Non-Small-Cell Lung
Location: Canton OH, Detroit MI, Milwaukee WI, New York NY,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06855771

Phase 2, Recruiting

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

for
Cancer, Melanoma Stage III, Melanoma Stage IV,
Location: Canton OH, Cleveland OH, Pittsburgh PA, Detroit MI,
Sponsor: Krystal Biotech, Inc.

Sex: All

Age: 18+

Code: NCT05970497

Phase 1, Phase 2, Recruiting

Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib

for
Carcinoma, Non-Small Cell Lung
Location: Canton OH, Lexington KY, Fairfax VA, Urbana IL,
Sponsor: Genprex, Inc.

Sex: All

Age: 18+

Code: NCT04486833

Phase 1, Phase 2, Recruiting

Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors

for
Acneiform Eruption Due to Chemical, Xerosis Cutis, Paronychia
Location: Canton OH, The Bronx NY, New Hyde Park NY, Mineola NY,
Sponsor: Hoth Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05639933

Phase 2, Recruiting

Study to Evaluate Maximum Tolerated Dose of Oral CB-03-10 With Dose Expansion Phase, in Advanced Solid Tumors

for
Advanced Refractory Solid Tumors,
Location: Ohio City OH, Michigan Center MI, New Haven CT,
Sponsor: Cosmo Technologies Ltd

Sex: All

Age: 18+

Code: NCT03863145

Early Phase 1, Recruiting

Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Lenalidomide in Multiple Myeloma (MM)

for
Multiple Myeloma
Location: Canton OH
Sponsor: Starton Therapeutics, Inc

Sex: All

Age: 18+

Code: NCT06087653

Phase 1, Phase 2, Recruiting

Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib

for
Myelofibrosis, Primary Myelofibrosis, Post-PV MF,
Location: Canton OH, Cincinnati OH, Birmingham AL, Houston TX
Sponsor: Telios Pharma, Inc.

Sex: All

Age: 18+

Code: NCT05280509

Phase 1, Phase 2, Recruiting

Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients

for
Small Cell Lung Cancer Extensive Stage
Location: Canton OH, Fairfield OH, Cincinnati OH, Fairfax VA,
Sponsor: Genprex, Inc.

Sex: All

Age: 18+

Code: NCT05703971

Phase 1, Phase 2, Recruiting

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

for
Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm,
Location: Canton OH, Cleveland OH, Bethesda MD, Fredericksburg VA,
Sponsor: BriaCell Therapeutics Corporation

Sex: All

Age: 18+

Code: NCT06072612

Phase 3, Recruiting